Mindful Walking Program for Older African Americans
Launched by UNIVERSITY OF SOUTH CAROLINA · Oct 12, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a mindful walking program on the brain health of older African American adults. The researchers want to find out if participating in this program can help improve or maintain cognitive function, which refers to how well we think, learn, and remember. The trial involves two groups: one group will start the mindful walking sessions right away, while the other group will wait a little longer before joining. By comparing these two groups, the researchers hope to see if mindful walking really makes a difference in cognitive health.
To be eligible for this study, participants must be African American adults aged 60 and older who are experiencing mild cognitive decline but are still able to walk independently. They should also be physically inactive and able to understand English. Participants will take part in sessions that involve walking mindfully, focusing on their surroundings and breathing, which can be a calming and beneficial practice. It's important to note that people with certain medical conditions or those who are currently involved in other similar studies won't be able to join. Overall, this study aims to explore a new way to support brain health in a community that may be at higher risk for cognitive decline.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. African American ages 60 and above
- • 2. Mild symptoms of cognitive decline or MCI
- • 3. Physically inactive or insufficiently active (based on the 2018 US guidelines)
- • 4. Adequate hearing and visual ability to complete study tasks and assessments
- • 5. English proficiency
- • 6. Medically stable with or without medication
- • 7. Capable of providing informed consent
- • 8. Willing to be randomized to one of the two groups
- Exclusion Criteria:
- • 1. Clinical diagnosis of ADRD or other brain abnormalities (e.g., strokes, epilepsy, Parkinson's disease
- • 2. Clinical diagnosis of psychiatric disorders (i.e., depression, post-traumatic stress disorder, bipolar disorder)
- • 3. Unable to walk independently (i.e., need caregiver's assistance) 4) Plan to have surgery or relocate outside the area within the next 6 months
- • 5) Currently participate in other studies involving physical activity, mindfulness, or cognitive training
About University Of South Carolina
The University of South Carolina (USC) is a leading research institution dedicated to advancing healthcare through innovative clinical trials and studies. With a commitment to excellence in research and education, USC leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical investigations aimed at improving patient outcomes and addressing pressing health challenges. Collaborating with a diverse network of healthcare professionals, researchers, and community partners, USC fosters an environment of discovery and translation, ensuring that findings from clinical trials contribute significantly to the advancement of medical science and evidence-based practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Columbia, South Carolina, United States
Patients applied
Trial Officials
Chih-Hsiang "Jason" Yang, PhD
Principal Investigator
University of South Carolina
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported